GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Ending Cash Position

Neurologix (Neurologix) Ending Cash Position : $3.45 Mil (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix Ending Cash Position?

Neurologix's Ending Cash Position for the quarter that ended in Jun. 2011 was $3.45 Mil.

Neurologix's quarterly Ending Cash Position declined from Dec. 2010 ($8.06 Mil) to Mar. 2011 ($5.44 Mil) and declined from Mar. 2011 ($5.44 Mil) to Jun. 2011 ($3.45 Mil).

Neurologix's annual Ending Cash Position declined from Dec. 2008 ($18.91 Mil) to Dec. 2009 ($9.64 Mil) and declined from Dec. 2009 ($9.64 Mil) to Dec. 2010 ($8.06 Mil).


Neurologix Ending Cash Position Historical Data

The historical data trend for Neurologix's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Ending Cash Position Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.48 20.16 18.91 9.64 8.06

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.51 3.00 8.06 5.44 3.45

Neurologix Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Neurologix's Ending Cash Position for the fiscal year that ended in Dec. 2010 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.637+-1.582
=8.06

Neurologix's Ending Cash Position for the quarter that ended in Jun. 2011 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=5.439+-1.986
=3.45


Neurologix Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Neurologix's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines